A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Current clinical trial and targeted therapy enrollment processes struggle with integrating diverse molecular data.
• Identifying genotype-matched patients is critical but hampered by existing methodologies.

Purpose of the Study:

• To develop a streamlined precision oncology platform for identifying eligible patients for clinical trials and targeted therapies.
• To assist molecular tumor boards and community oncologists in patient data review and treatment matching.

Main Methods:

• Development of a novel precision oncology platform.
• Integration of diverse molecular data sources.
• Facilitation of patient phenotype review and knowledge evaluation.

Main Results:

• The platform enables efficient identification of genotype-matched individuals.
• It supports molecular tumor boards and community oncologists in decision-making.
• Streamlined access to targeted therapies and clinical trials is facilitated.

Conclusions:

• The developed precision oncology platform addresses the critical need for efficient patient identification.
• It enhances the process of matching patients to genotype-matched therapies and clinical trials.
• This tool improves precision medicine by simplifying complex data analysis for oncologists.